SCHEMBL5773778

SCHEMBL5773778

O=C(N(CCCc1cnoc1-c1ccc(F)cc1)CCN1CCCC1)C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G7 Q13093 4/20 0.36
CYP3A4 P08684 2/20 0.36
SIGMAR1 Q99720 1/20 0.35
KCNH2 Q12809 4/20 0.35
CHRNA3 P32297 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
HTR4 Q13639 1/20 0.35
HTR3A P46098 1/20 0.35
HDAC8 Q9BY41 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
DRD2 P14416 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5775676 0.99 PLA2G7 (0.37) PLA2G7CYP3A4SIGMAR1KCNH2CHRNA3
SCHEMBL5777116 0.93 CD274 (0.41) PLA2G7ALDH1A1KDM4ETSHRCNR2
SCHEMBL5773350 0.89 TSHR (0.40) PLA2G7CYP3A4SIGMAR1DRD2HTR2A
SCHEMBL5774298 0.89 TSHR (0.42) PLA2G7ALDH1A1KDM4ETSHRCNR2
SCHEMBL5773426 0.84 ACHE (0.41) CYP3A4HTR2AALDH1A1KDM4ETSHR
SCHEMBL5777440 0.83 HDAC8 (0.35) PLA2G7CYP3A4HDAC8HDAC4KDM4E
SCHEMBL5777281 0.81 HDAC8 (0.34) CYP3A4HDAC8ALDH1A1KDM4E
SCHEMBL5773577 0.80 NAMPT (0.35) SIGMAR1KCNH2HDAC8HDAC4HDAC1
SCHEMBL5775799 0.80 HDAC8 (0.34) PLA2G7HDAC8
SCHEMBL5773637 0.80 CYP19A1 (0.44) HDAC4HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR PLA2G7 2423/4885CYP3A4 39/4885SIGMAR1 653/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 PLA2G7 1986/4885CYP3A4 76/4885SIGMAR1 874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.